NCT04525417

Rapid Screening Test for Covid-19 Antibodies in Healthcare Workers

Use of Rapid Covid-19 Antibody Test Marketed by AAZ Laboratories in Healthcare Workers Presumably Being Infected by SARS-CoV-2

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 75 (actual)
• Sponsor: Groupe d'Etude sur le Risque d'Exposition des Soignants aux Agents Infectieux · Network
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The study objectives were to assess 1/the immune status of healthcare professionals with suggestive symptomatology of Covid-19 infection and 2/the sensitivity and specificity of AAZ rapid test by comparing it with a serological ELISA test. An open-label, monocentric, prospective, non-randomized study, is conducted, including 50 hospital healthcare professionals and 50 private health professionals. Knowledge of serostatus will achieve the implementation of a strategy of management of patients according to specific immunity of health professionals

Conditions

• Covid-19 Immune Status of Healthcare Workers

Interventions

Type	Name	Description
DIAGNOSTIC_TEST	AAZ Covid-19 rapid test	To assess the immune status

Timeline

• Start date: 2020-04-25
• Primary completion: 2020-09-25
• Completion: 2020-10-25
• First posted: 2020-08-25
• Last updated: 2021-02-03

Locations

1 site across 1 country: France